These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38792805)

  • 61. A prediction nomogram for hepatitis B virus-associated hepatocellular carcinoma.
    Zhang Y; Wan G; Li H; Gao L; Liu N; Gao P; Liu Y; Gao X; Duan X
    Scand J Gastroenterol; 2024; 59(1):70-77. PubMed ID: 37647217
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Machine Learning-Based Development of Nomogram for Hepatocellular Carcinoma to Predict Acute Liver Function Deterioration After Drug-Eluting Beads Transarterial Chemoembolization.
    Li J; Zhang Y; Ye H; Hu L; Li X; Li Y; Yu P; Wu B; Lv P; Li Z
    Acad Radiol; 2023 Sep; 30 Suppl 1():S40-S52. PubMed ID: 37316369
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
    Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
    Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.
    Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W
    BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators.
    Yu X; Yang R; He Z; Zeng P
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8969-8979. PubMed ID: 37160627
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma.
    Fang Q; Yang R; Chen D; Fei R; Chen P; Deng K; Gao J; Liao W; Chen H
    Front Oncol; 2021; 11():646638. PubMed ID: 33842361
    [No Abstract]   [Full Text] [Related]  

  • 69. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
    Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
    Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.
    Yu B; Liang H; Ye Q; Wang Y
    J Gastrointest Surg; 2021 Jan; 25(1):112-124. PubMed ID: 32128678
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma.
    Li X; Bi X; Zhao J; Li Z; Zhou J; Huang Z; Zhang Y; Zhao H; Cai J
    Transl Cancer Res; 2021 Apr; 10(4):1773-1786. PubMed ID: 35116501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy.
    Qiao W; Wang Q; Mei T; Wang Q; Wang W; Zhang Y
    Front Surg; 2023; 10():1045213. PubMed ID: 36936655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients.
    Wang S; Zhang X; Chen Q; Jin ZC; Lu J; Guo J
    J Hepatocell Carcinoma; 2023; 10():659-671. PubMed ID: 37113464
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.
    Zhang JS; Wang ZH; Guo XG; Zhang J; Ni JS
    J Gastrointest Oncol; 2022 Feb; 13(1):298-310. PubMed ID: 35284131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.
    Ye JZ; Mai RY; Guo WX; Wang YY; Ma L; Xiang BD; Cheng SQ; Li LQ
    BMC Cancer; 2020 Oct; 20(1):1036. PubMed ID: 33115425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.